122 related articles for article (PubMed ID: 21173040)
1. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
Wilson SM; Sheddan NA; Newton R; Giembycz MA
Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
[TBL] [Abstract][Full Text] [Related]
2. 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 release.
Ayer LM; Wilson SM; Traves SL; Proud D; Giembycz MA
J Pharmacol Exp Ther; 2008 Feb; 324(2):815-26. PubMed ID: 17962517
[TBL] [Abstract][Full Text] [Related]
3. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
[TBL] [Abstract][Full Text] [Related]
4. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
Zhou W; Blackwell TS; Goleniewska K; O'Neal JF; Fitzgerald GA; Lucitt M; Breyer RM; Peebles RS
J Leukoc Biol; 2007 Mar; 81(3):809-17. PubMed ID: 17135575
[TBL] [Abstract][Full Text] [Related]
6. Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.
Morrison K; Ernst R; Hess P; Studer R; Clozel M
J Pharmacol Exp Ther; 2010 Oct; 335(1):249-55. PubMed ID: 20660124
[TBL] [Abstract][Full Text] [Related]
7. Localization of IP in rabbit kidney and functional role of the PGI(2)/IP system in cortical collecting duct.
Nasrallah R; Nusing RM; Hébert RL
Am J Physiol Renal Physiol; 2002 Oct; 283(4):F689-98. PubMed ID: 12217860
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the PGI2/IP system in cultured rat mesangial cells.
Nasrallah R; Landry A; Scholey JW; Hébert RL
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):455-64. PubMed ID: 15062848
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.
Sprague RS; Bowles EA; Hanson MS; DuFaux EA; Sridharan M; Adderley S; Ellsworth ML; Stephenson AH
Microcirculation; 2008 Jul; 15(5):461-71. PubMed ID: 18574748
[TBL] [Abstract][Full Text] [Related]
10. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
Rowlands DK; Kao C; Wise H
Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
[TBL] [Abstract][Full Text] [Related]
11. Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
Parfenova H; Hsu P; Leffler CW
J Pharmacol Exp Ther; 1995 Jan; 272(1):44-52. PubMed ID: 7529312
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of prostaglandin I(2) analogs on ischemic delayed neuronal damage in gerbils.
Cui Y; Kataoka Y; Satoh T; Yamagata A; Shirakawa N; Watanabe Y; Suzuki M; Yanase H; Kataoka K; Watanabe Y
Biochem Biophys Res Commun; 1999 Nov; 265(2):301-4. PubMed ID: 10558861
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
14. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
Darius H; Binz C; Veit K; Fisch A; Meyer J
J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
[TBL] [Abstract][Full Text] [Related]
15. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
Orie NN; Clapp LH
Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
[TBL] [Abstract][Full Text] [Related]
16. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
[TBL] [Abstract][Full Text] [Related]
17. A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons.
Nakae K; Saito K; Iino T; Yamamoto N; Wakabayashi M; Yoshikawa S; Matsushima S; Miyashita H; Sugimoto H; Kiba A; Gupta J
J Pharmacol Exp Ther; 2005 Dec; 315(3):1136-42. PubMed ID: 16109742
[TBL] [Abstract][Full Text] [Related]
18. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
Jones RL; Chan K
Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
[TBL] [Abstract][Full Text] [Related]
19. Involvement of prostacyclin/IP receptors in decreased acid response of damaged stomachs--mediation by somatostatin/SST2 receptors.
Terashima S; Nishio H; Ogura M; Honda M; Takeuchi K
Life Sci; 2009 Jan; 84(5-6):172-80. PubMed ID: 19070625
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin I(2) analogues enhance growth-related oncogene-alpha expression in human monocyte-derived dendritic cells.
Kuo CH; Jan RL; Chu YT; Wang WL; Huang MY; Huang CH; Chen TH; Hung CH
Inflammation; 2010 Oct; 33(5):334-43. PubMed ID: 20195728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
